Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids.

Wu, Xiaoshan; Jiang, Dacheng; Yang, Yi; Li, Shuang; Ding, Qiurong

Wu, Xiaoshan; Jiang, Dacheng; Yang, Yi; Li, Shuang; Ding, Qiurong.

Afiliação

Wu X; School of Biotechnology, East China University of Science and Technology, Shanghai, 200237, P. R. China.
Jiang D; CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, P. R. China.
Yang Y; School of Pharmacy, Fujian Health College, Fujian, 350101, P. R. China.
Li S; CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, University of Chinese Academy of Sciences, Chinese Academy of Sciences, Shanghai, 200031, P. R. China.
Ding Q; School of Biotechnology, East China University of Science and Technology, Shanghai, 200237, P. R. China.

Cell Regen ; 12(1): 6, 2023 Mar 03.

Article em En | MEDLINE | ID: mdl-36864321

Palavras-chave

Anti-fibrotic compounds; Drug-induced liver injury; High-content analysis; Human liver organoid; Pluripotent stem cell

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Cell Regen Ano de publicação: 2023 Tipo de documento: Article País de publicação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google